Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 331

1.

Proinflammatory bacterial peptidoglycan as a cofactor for the development of central nervous system autoimmune disease.

Visser L, Jan de Heer H, Boven LA, van Riel D, van Meurs M, Melief MJ, Zähringer U, van Strijp J, Lambrecht BN, Nieuwenhuis EE, Laman JD.

J Immunol. 2005 Jan 15;174(2):808-16.

PMID:
15634902
[PubMed - indexed for MEDLINE]
Free Article
2.

Presentation of the self antigen myelin basic protein by dendritic cells leads to experimental autoimmune encephalomyelitis.

Dittel BN, Visintin I, Merchant RM, Janeway CA Jr.

J Immunol. 1999 Jul 1;163(1):32-9.

PMID:
10384096
[PubMed - indexed for MEDLINE]
Free Article
3.

Autoimmune intervention by CD154 blockade prevents T cell retention and effector function in the target organ.

Howard LM, Miller SD.

J Immunol. 2001 Feb 1;166(3):1547-53.

PMID:
11160195
[PubMed - indexed for MEDLINE]
Free Article
5.
6.

De novo central nervous system processing of myelin antigen is required for the initiation of experimental autoimmune encephalomyelitis.

Tompkins SM, Padilla J, Dal Canto MC, Ting JP, Van Kaer L, Miller SD.

J Immunol. 2002 Apr 15;168(8):4173-83.

PMID:
11937578
[PubMed - indexed for MEDLINE]
Free Article
8.

Experimental autoimmune encephalomyelitis induction in naive mice by dendritic cells presenting a self-peptide.

Weir CR, Nicolson K, Bäckström BT.

Immunol Cell Biol. 2002 Feb;80(1):14-20.

PMID:
11869358
[PubMed - indexed for MEDLINE]
Free Article
9.

Neuropeptide Y (NPY) suppresses experimental autoimmune encephalomyelitis: NPY1 receptor-specific inhibition of autoreactive Th1 responses in vivo.

Bedoui S, Miyake S, Lin Y, Miyamoto K, Oki S, Kawamura N, Beck-Sickinger A, von Hörsten S, Yamamura T.

J Immunol. 2003 Oct 1;171(7):3451-8.

PMID:
14500640
[PubMed - indexed for MEDLINE]
Free Article
10.

Pertussis toxin enhances Th1 responses by stimulation of dendritic cells.

Hou W, Wu Y, Sun S, Shi M, Sun Y, Yang C, Pei G, Gu Y, Zhong C, Sun B.

J Immunol. 2003 Feb 15;170(4):1728-36.

PMID:
12574336
[PubMed - indexed for MEDLINE]
Free Article
11.

Stromal interaction molecules 1 and 2 are key regulators of autoreactive T cell activation in murine autoimmune central nervous system inflammation.

Schuhmann MK, Stegner D, Berna-Erro A, Bittner S, Braun A, Kleinschnitz C, Stoll G, Wiendl H, Meuth SG, Nieswandt B.

J Immunol. 2010 Feb 1;184(3):1536-42. doi: 10.4049/jimmunol.0902161. Epub 2009 Dec 18.

PMID:
20028655
[PubMed - indexed for MEDLINE]
Free Article
12.

IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis.

Komiyama Y, Nakae S, Matsuki T, Nambu A, Ishigame H, Kakuta S, Sudo K, Iwakura Y.

J Immunol. 2006 Jul 1;177(1):566-73.

PMID:
16785554
[PubMed - indexed for MEDLINE]
Free Article
13.

Recombinant TCR ligand induces tolerance to myelin oligodendrocyte glycoprotein 35-55 peptide and reverses clinical and histological signs of chronic experimental autoimmune encephalomyelitis in HLA-DR2 transgenic mice.

Vandenbark AA, Rich C, Mooney J, Zamora A, Wang C, Huan J, Fugger L, Offner H, Jones R, Burrows GG.

J Immunol. 2003 Jul 1;171(1):127-33.

PMID:
12816990
[PubMed - indexed for MEDLINE]
Free Article
14.

ERK1-deficient mice show normal T cell effector function and are highly susceptible to experimental autoimmune encephalomyelitis.

Nekrasova T, Shive C, Gao Y, Kawamura K, Guardia R, Landreth G, Forsthuber TG.

J Immunol. 2005 Aug 15;175(4):2374-80.

PMID:
16081808
[PubMed - indexed for MEDLINE]
Free Article
15.

Peroxisome proliferator-activated receptor-gamma-deficient heterozygous mice develop an exacerbated neural antigen-induced Th1 response and experimental allergic encephalomyelitis.

Natarajan C, Muthian G, Barak Y, Evans RM, Bright JJ.

J Immunol. 2003 Dec 1;171(11):5743-50. Erratum in: J Immunol. 2004 Apr 15;172(8):following 5127.

PMID:
14634082
[PubMed - indexed for MEDLINE]
Free Article
16.

Cellular FLIP (long isoform) overexpression in T cells drives Th2 effector responses and promotes immunoregulation in experimental autoimmune encephalomyelitis.

Tseveleki V, Bauer J, Taoufik E, Ruan C, Leondiadis L, Haralambous S, Lassmann H, Probert L.

J Immunol. 2004 Dec 1;173(11):6619-26.

PMID:
15557152
[PubMed - indexed for MEDLINE]
Free Article
17.

IFN-inducible protein 10/CXC chemokine ligand 10-independent induction of experimental autoimmune encephalomyelitis.

Klein RS, Izikson L, Means T, Gibson HD, Lin E, Sobel RA, Weiner HL, Luster AD.

J Immunol. 2004 Jan 1;172(1):550-9.

PMID:
14688366
[PubMed - indexed for MEDLINE]
Free Article
18.

CD1-dependent regulation of chronic central nervous system inflammation in experimental autoimmune encephalomyelitis.

Teige A, Teige I, Lavasani S, Bockermann R, Mondoc E, Holmdahl R, Issazadeh-Navikas S.

J Immunol. 2004 Jan 1;172(1):186-94.

PMID:
14688325
[PubMed - indexed for MEDLINE]
Free Article
19.

Deficiency of fatty acid-binding proteins in mice confers protection from development of experimental autoimmune encephalomyelitis.

Reynolds JM, Liu Q, Brittingham KC, Liu Y, Gruenthal M, Gorgun CZ, Hotamisligil GS, Stout RD, Suttles J.

J Immunol. 2007 Jul 1;179(1):313-21.

PMID:
17579051
[PubMed - indexed for MEDLINE]
Free Article
20.

Differential effects of IL-21 during initiation and progression of autoimmunity against neuroantigen.

Vollmer TL, Liu R, Price M, Rhodes S, La Cava A, Shi FD.

J Immunol. 2005 Mar 1;174(5):2696-701.

PMID:
15728477
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk